RESMED
RESMED operates in Diversified Metals & Mining.
RESMED (RME) - Total Liabilities
Latest total liabilities as of September 2024: €2.03 Billion EUR
Based on the latest financial reports, RESMED (RME) has total liabilities worth €2.03 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
RESMED - Total Liabilities Trend (2016–2024)
This chart illustrates how RESMED's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
RESMED Competitors by Total Liabilities
The table below lists competitors of RESMED ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nevada Exploration Inc
OTCQB:NVDEF
|
USA | $459.92K |
|
My Size Inc
NASDAQ:MYSZ
|
USA | $4.36 Million |
|
ASSURANT
BE:ZAS
|
Germany | €30.08 Billion |
|
Versus Systems Inc
NASDAQ:VS
|
USA | $3.46K |
|
Verena Multi Finance Tbk
JK:VRNA
|
Indonesia | Rp2.32 Trillion |
|
Trillium Gold Mines Inc
OTCQX:TGLDF
|
USA | $3.06 Million |
|
Birks Group Inc
NYSE MKT:BGI
|
USA | $233.73 Million |
|
GHST World Inc
PINK:GHST
|
USA | $542.33K |
Liability Composition Analysis (2016–2024)
This chart breaks down RESMED's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RESMED's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RESMED (2016–2024)
The table below shows the annual total liabilities of RESMED from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | €2.01 Billion | -23.40% |
| 2023-06-30 | €2.62 Billion | +51.10% |
| 2022-06-30 | €1.74 Billion | -5.83% |
| 2021-06-30 | €1.84 Billion | -11.86% |
| 2020-06-30 | €2.09 Billion | +2.70% |
| 2019-06-30 | €2.04 Billion | +102.55% |
| 2018-06-30 | €1.00 Billion | -33.37% |
| 2017-06-30 | €1.51 Billion | -3.57% |
| 2016-06-30 | €1.56 Billion | -- |